DK Life Science Co., Ltd. (KOSDAQ:303810)

DK Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	110,665	117,062	-	-	-	-
Enterprise Value	142,395	147,385	-	-	-	-
Last Close Price	3460.00	3660.00	-	-	-	-
PE Ratio	12.58	13.52	-	-	-	-
PS Ratio	0.85	0.90	-	-	-	-
PB Ratio	0.84	0.89	-	-	-	-
P/TBV Ratio	0.88	0.93	-	-	-	-
P/OCF Ratio	255.20	269.95	-	-	-	-
EV/Sales Ratio	1.09	1.13	-	-	-	-
EV/EBITDA Ratio	7.32	7.58	-	-	-	-
EV/EBIT Ratio	10.92	11.30	-	-	-	-
Debt / Equity Ratio	0.30	0.30	0.43	0.49	0.46	0.28
Debt / EBITDA Ratio	2.00	2.00	2.56	4.03	4.81	2.55
Debt / FCF Ratio	-	-	7.01	-	-	-
Net Debt / Equity Ratio	0.24	0.24	0.39	0.45	0.41	0.18
Net Debt / EBITDA Ratio	1.63	1.63	2.30	3.71	4.29	1.65
Net Debt / FCF Ratio	-6.04	-6.04	6.30	-4.66	-1.84	-0.61
Asset Turnover	0.64	0.64	0.71	0.70	0.69	0.76
Inventory Turnover	2.51	2.51	2.52	2.75	3.45	4.90
Quick Ratio	1.23	1.23	1.11	0.98	1.09	1.03
Current Ratio	1.72	1.72	1.84	1.62	1.72	1.46
Return on Equity (ROE)	7.32%	7.32%	2.22%	4.46%	4.90%	7.45%
Return on Assets (ROA)	3.98%	3.98%	4.02%	3.10%	2.49%	3.16%
Return on Invested Capital (ROIC)	6.44%	6.75%	3.93%	5.49%	4.44%	7.94%
Return on Capital Employed (ROCE)	9.50%	9.50%	9.30%	7.40%	5.40%	7.30%
Earnings Yield	7.82%	7.40%	-	-	-	-
FCF Yield	-4.75%	-4.49%	-	-	-	-
Buyback Yield / Dilution	-12.21%	-12.21%	-2406.42%	-0.00%	-0.01%	2.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.